KMED

KraneShares Emerging Market Healthcare Index ETF

Download KMED Presentation

Download Fact Sheet

Investment Strategy:

KMED seeks to provide investment results that, before fees and expenses, track the performance of the Solactive Emerging Markets Healthcare Index. The index seeks to track the equity market performance of companies engaged in the health care sector in various emerging markets. The issuers include small-cap, mid-cap, and large-cap companies involved in hospital management, healthcare management, pharmaceutical manufacturing, and biotechnology, among other sub-industries.

Emerging Market Healthcare Sector Highlights:

  • By 2040, emerging market countries on average are projected to increase healthcare spending as percent of GDP by 24.4% compared to just 9.8% in developed markets over the same time period1.
  • In emerging markets, rapid urbanization and rising income is fueling growth in the demand for healthcare services and treatments.
  • Cases of non-communicable diseases (NCDs) such as diabetes and cancer are rising steadily in emerging market countries, presenting a growth opportunity for innovators in the healthcare space.
  • Emerging markets governments are enacting policies such as India’s “National Health Protection Mission” and China’s “Healthy China 2030 Plan” to meet the growing demand for healthcare.

KMED features:

  • Exposure to the Emerging Market healthcare industry with a low correlation to US healthcare equities. Specifically: pharmaceuticals, biotechnology, healthcare administration services, and medical equipment.
  • Access to emerging market innovators in healthcare and pharmaceutical research.
  • Exposure to companies that benefit from the growing and aging EM populations.

1.) Dieleman, Joseph L et al., “Future and potential spending on health 2015–40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries”, The Lancet , Volume 389 , Issue 10083 , 2005 - 2030.

Fund Details

Data as of 07/02/2020
TickerKMED
Primary ExchangeNYSE
CUSIP500767819
ISINUS5007678197
Net Assets$1,416,259
Total Annual Fund Operating Expense0.79%
Inception Date8/29/18
Distribution FrequencyAnnual

Daily Performance

Data as of 07/02/2020
Premium Discount Chart
NAV
Net Asset Value$28.32 
Daily Change0.97%
Price
Closing Price$0.00 
Daily Change0.00%

Performance History

Distributions
Cumulative %
Data as of: 06/30/2020
Fund NAVClosing PriceIndex
1 Month13.95%13.83%14.06%
3 Month35.20%35.83%35.70%
6 Month25.01%26.82%25.70%
Since Inception14.69%15.22%16.25%
Avg Annualized %
Data as of quarter end: 06/30/2020
Fund NAVClosing PriceIndex
1 Year36.33%37.41%36.82%
Since Inception7.74% 8.01%8.53%

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted.

Top 10 Holdings

Data as of 07/02/2020
Full Holdings .CSV
RankCompany Name% of Net AssetsTickerShares HeldMarket Value($)
1
CELLTRION INC
5.65%068270 KS31179,956
2
SAMSUNG BIOLOGICS CO LTD
5.09%207940 KS11072,053
3
SHENZHEN MINDR-A
4.06%300760 C21,40057,532
4
JIANGSU HENGRU-A
4.03%600276 CH4,42657,085
5
SUN PHARMACEUTICAL INDUS
3.99%SUNP IN8,97056,559
6
CELLTRION HEALTH
3.99%091990 KS61956,486
7
HARTALEGA HOLDINGS BHD
3.19%HART MK12,90045,147
8
IHH HEALTHCARE BHD
3.09%IHH MK34,40043,742
9
TOP GLOVE CORP BHD
2.62%TOPG MK9,10037,156
10
DR. REDDY'S LABORATORIES
2.39%DRRD IN64733,815

Holdings are subject to change.